Pharmacologic therapy for asthma: overview and historical perspective
- PMID: 10073318
Pharmacologic therapy for asthma: overview and historical perspective
Abstract
For the 30 years between 1967 and 1997, pharmacologic therapy of asthma has consisted primarily of five classes of drugs, beta 2-agonists, anticholinergics, theophyllines, cromones, and corticosteroids. The first four of these classes of drugs have origins in herbal treatments going back 5000 or 6000 years. This article briefly reviews the history of asthma pharmacotherapy up to the late 1990s and outlines a current approach to the pharmacotherapy of asthma, which is but one component of an integrated overall approach to asthma treatment involving patient education and environmental control as well.
Similar articles
-
Asthma: one hundred years of treatment and onward.Am J Respir Crit Care Med. 2005 Jun 1;171(11):1202-8. doi: 10.1164/rccm.200502-257OE. Epub 2005 Mar 18. Am J Respir Crit Care Med. 2005. PMID: 15778490
-
Summing up 100 years of asthma.Respir Med. 2007 Mar;101(3):378-88. doi: 10.1016/j.rmed.2006.12.004. Epub 2007 Jan 26. Respir Med. 2007. PMID: 17258900 Review.
-
Pharmacogenetics of asthma.Methods Mol Biol. 2008;448:359-78. doi: 10.1007/978-1-59745-205-2_11. Methods Mol Biol. 2008. PMID: 18370237 Review.
-
Blocking asthmatic progression and chronicity in the pre-corticosteroid era.J Allergy Clin Immunol. 2008 Mar;121(3):787-90. doi: 10.1016/j.jaci.2008.01.024. J Allergy Clin Immunol. 2008. PMID: 18328904 No abstract available.
-
A patient with asthma seeks medical advice in 1828, 1928, and 2012.N Engl J Med. 2012 Mar 1;366(9):827-34. doi: 10.1056/NEJMra1102783. N Engl J Med. 2012. PMID: 22375974 No abstract available.
Cited by
-
Clinical concerns with inhaled beta2-agonists: adult asthma.Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):197-208. doi: 10.1385/CRIAI:31:2:197. Clin Rev Allergy Immunol. 2006. PMID: 17085793 Review.
-
A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.J Biol Chem. 2015 Jan 23;290(4):1966-78. doi: 10.1074/jbc.M114.586602. Epub 2014 Dec 2. J Biol Chem. 2015. PMID: 25468905 Free PMC article.
-
Beta2-agonists and bronchial hyperresponsiveness.Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):143-62. doi: 10.1385/CRIAI:31:2:143. Clin Rev Allergy Immunol. 2006. PMID: 17085790 Review.
-
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679. Handb Exp Pharmacol. 2024. PMID: 37709918 Review.
-
Asthma and therapeutics: recombinant therapies in asthma.Allergy Asthma Clin Immunol. 2005 Mar 15;1(1):34-41. doi: 10.1186/1710-1492-1-1-34. Epub 2005 Mar 15. Allergy Asthma Clin Immunol. 2005. PMID: 20529233 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical